Alain Prochiantz
14Patents
3h-index
20Co-inventors
60Inventor score
Filing activity: May 5, 1994 → Jun 17, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5888762A | Neurotropic growth factors comprising a homeobox peptide | Human Necessities | 41 | Expired |
| US6080724A | Peptides which can be used as vectors for the intracellular addressing of active molecules | Chemistry; Metallurgy | 36 | Expired |
| US10100307B2 | Use of a reverse-transcriptase inhibitor in the prevention and treatment of degenerative diseases | Chemistry; Metallurgy | 6 | Active |
| US8242088B2 | Carrier vectors through an epithelium with tight junctions | Performing Operations; Transporting | 3 | Expired |
| US8575105B2 | Use of the engrailed homeodomain protein as anxiolytic | Human Necessities | 2 | Active |
| US6656735B1 | Method for identification of target genes of transcription factors | Chemistry; Metallurgy | 1 | Expired |
| US9950033B2 | Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neurons | Human Necessities | 1 | Active |
| US10342851B2 | Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neurons | Human Necessities | 0 | Active |
| US7115380B2 | Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP) | Human Necessities | 0 | Expired |
| US10842852B2 | Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide | Physics | 0 | Active |
| US9868783B2 | Inhibition of the synthesis of beta-app or the activity of the A-β peptide in the choroid plexus | Chemistry; Metallurgy | 0 | Active |
| US6905832B1 | Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (APP) | Human Necessities | 0 | Expired |
| US10722554B2 | Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoprotein | Emerging Cross-Sectional Technologies | 0 | Active |
| US11357816B2 | Ligand controling interaction between gags with their effector molecules and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.